Filed: 8/14/2026ACC: 0001104659-26-097081
📋 What this filing means
DCVC OPPORTUNITY FUND II GP, LLC filed this quarterly 13F‑HR report disclosing 2 equity positions with a total reported market value of $17.20M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
2
Positions
$17.20M
Total AUM (reported)
4M
Total Shares
Allocation by class
CL A$17.20M100.0%
Portfolio Concentration
Top 3$17.20M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 4M
Sole
Full voting authority
4M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole2
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings2
Rows:
Recursion Pharmaceuticals, Inc.
SOLEShares3.95M
TypeSH
Market value$14.50M
84.30%
Sole
3.95M
Shared
0.00
None
0.00
IonQ, Inc.
SOLEShares50.70K
TypeSH
Market value$2.70M
15.70%
Sole
50.70K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Recursion Pharmaceuticals, Inc.SOLE | CL A | 3.95M | SH | $14.50M 84.30% | 3.95M | 0.00 | 0.00 |
IonQ, Inc.SOLE | CL A | 50.70K | SH | $2.70M 15.70% | 50.70K | 0.00 | 0.00 |